相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial
Marcus Hjort et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)
Growth Differentiation Factor 15: A Prognostic Marker in Patients with Acute Chest Pain without Acute Myocardial Infarction
Gard M. S. Myrmel et al.
CLINICAL CHEMISTRY (2023)
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
Eri Toda Kato et al.
EUROPEAN HEART JOURNAL (2023)
Predictors of long-term symptom burden and quality of life in patients hospitalised with chest pain: a prospective observational study
Nasir Saeed et al.
BMJ OPEN (2022)
Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: the WESTCOR study
Ole-Thomas Steiro et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)
Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study)
Nermina Buljubasic et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design
Hilde L. Tjora et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2019)
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert et al.
CLINICAL CHEMISTRY (2017)
Growth Differentiation Factor 15 Predicts AM-Cause Morbidity and Mortality in Stable Coronary Heart Disease
Emil Hagstrom et al.
CLINICAL CHEMISTRY (2017)
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
Daniel Lindholm et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy
Ioannis Tentzeris et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
An Automated Assay for Growth Differentiation Factor 15
Kai C. Wollert et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2017)
Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated Troponins
Laura Sarkisian et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention
Guillaume Laugaudin et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2016)
Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay
Tobias Reichlin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)
Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study
Gad Cotter et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela et al.
JOURNAL OF DIABETES RESEARCH (2015)
Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis
H. Yilmaz et al.
HERZ (2015)
Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: An Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy
Peter Damman et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome Observations From PROVE IT-TIMI 22
Marc P. Bonaca et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
Tibor Kempf et al.
NATURE MEDICINE (2011)
Growth- Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non-ST-Segment-Elevation Acute Coronary Syndrome
Kai M. Eggers et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome
Stefan Buchner et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Association of early follow-up after acute myocardial infarction with higher rates of medication use
Stacie L. Daugherty et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
Tibor Kempf et al.
EUROPEAN HEART JOURNAL (2007)
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay
Tibor Kempf et al.
CLINICAL CHEMISTRY (2007)
分享论文
